4.6 Article

Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames

期刊

JOURNAL OF IMMUNOLOGY
卷 202, 期 12, 页码 3370-3380

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1900070

关键词

-

资金

  1. National Health and Medical Research Council (NHMRC) [433608, 542508]
  2. NHMRC Senior Research Fellowship [603104]
  3. NHMRC Program [567122]
  4. NHMRC Biomedical Postgraduate scholarship
  5. National Health and Medical Research Council of Australia [603104] Funding Source: NHMRC
  6. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001014, ZIAAI001211, ZIAAI001210] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The importance of antiviral CD8(+) T cell recognition of alternative reading frame (ARF)-derived peptides is uncertain. In this study, we describe an epitope (NS1-ARF2(1-8)) present in a predicted 14-residue peptide encoded by the +1 register of NS1 mRNA in the influenza A virus (IAV). NS1-ARF2(1-8) elicits a robust, highly functional CD8(+) T cell response in IAV-infected BALB/c mice. NS1-ARF2(1-8) is presented from unspliced NS mRNA, likely from downstream initiation on a Met residue that comprises the P1 position of NS1-ARF2(1-8). Derived from a 14-residue peptide with no apparent biological function and negligible impacts on IAV infection, infectivity, and pathogenicity, NS1-ARF2(1-8) provides a clear demonstration of how immunosurveillance exploits natural errors in protein translation to provide antiviral immunity. We further show that IAV infection enhances a model cellular ARF translation, which potentially has important implications for virus-induced autoimmunity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

In vitro characterisation of SARS-CoV-2 and susceptibility of domestic ferrets (Mustela putorius furo)

Glenn A. Marsh, Alexander J. McAuley, Sheree Brown, Elizabeth A. Pharo, Sandra Crameri, Gough G. Au, Michelle L. Baker, Jennifer A. Barr, Jemma Bergfeld, Matthew P. Bruce, Kathie Burkett, Peter A. Durr, Clare Holmes, Leonard Izzard, Rachel Layton, Suzanne Lowther, Matthew J. Neave, Timothy Poole, Sarah-Jane Riddell, Brenton Rowe, Elisha Soldani, Vittoria Stevens, Willy W. Suen, Vinod Sundaramoorthy, Mary Tachedjian, Shawn Todd, Lee Trinidad, Sinead M. Williams, Julian D. Druce, Trevor W. Drew, Seshadri S. Vasan

Summary: Researchers made efforts early in the SARS-CoV-2 outbreak to propagate and characterize an Australian isolate of the virus in vitro and in an ex vivo model of human airway epithelium, as well as to demonstrate the susceptibility of domestic ferrets to SARS-CoV-2 infection following intranasal challenge.

TRANSBOUNDARY AND EMERGING DISEASES (2022)

Article Virology

Direct Priming of CD8+ T Cells Persists in the Face of Cowpox Virus Inhibitors of Antigen Presentation

Leon C. W. Lin, Sarah N. Croft, Nathan P. Croft, Yik Chun Wong, Stewart A. Smith, Swee-Seong Tang, Anthony W. Purcell, David C. Tscharke

Summary: The study investigated the CD8(+) T cell priming pathways for Vaccinia virus (VACV) by engineering the virus to express inhibitors of antigen presentation. While the inhibitors had diverse impacts on CD8(+) T cell responses, unexpectedly, the direct priming of CD8(+) T cells by poxviruses was robust enough to withstand potent viral inhibitors of antigen presentation. This demonstrates the flexibility and robustness of immune processes in activating immune responses required to fight infection.

JOURNAL OF VIROLOGY (2021)

Article Immunology

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity

Thi H. O. Nguyen, Louise C. Rowntree, Jan Petersen, Brendon Y. Chua, Luca Hensen, Lukasz Kedzierski, Carolien E. van de Sandt, Priyanka Chaurasia, Hyon-Xhi Tan, Jennifer R. Habel, Wuji Zhang, Lilith F. Allen, Linda Earnest, Kai Yan Mak, Jennifer A. Juno, Kathleen Wragg, Francesca L. Mordant, Fatima Amanat, Florian Krammer, Nicole A. Mifsud, Denise L. Doolan, Katie L. Flanagan, Sabrina Sonda, Jasveen Kaur, Linda M. Wakim, Glen P. Westall, Fiona James, Effie Mouhtouris, Claire L. Gordon, Natasha E. Holmes, Olivia C. Smibert, Jason A. Trubiano, Allen C. Cheng, Peter Harcourt, Patrick Clifton, Jeremy Chase Crawford, Paul G. Thomas, Adam K. Wheatley, Stephen J. Kent, Jamie Rossjohn, Joseph Torresi, Katherine Kedzierska

Summary: This study characterized CD8(+) T cells specific for SARS-CoV-2 epitopes in COVID-19 patients and unexposed individuals, revealing that CD8(+) T cells specific for the immunodominant B7/N-105 epitope were detected at high frequencies both before and during acute COVID-19 and convalescence. The research also showed high naive precursor frequency and TCR alpha beta diversity within immunodominant B7/N-105-specific CD8(+) T cells, shedding light on the origins and responses of SARS-CoV-2-specific T cells.

IMMUNITY (2021)

Article Immunology

Ptpn2 and KLRG1 regulate the generation and in skin

Katharina Hochheiser, Florian Wiede, Teagan Wagner, David Freestone, Matthias H. Enders, Moshe Olshansky, Brendan Russ, Simone Nussing, Emma Bawden, Asolina Braun, Annabell Bachem, Elise Gressier, Robyn McConville, Simone L. Park, Claerwen M. Jones, Gayle M. Davey, David E. Gyorki, David Tscharke, Ian A. Parish, Stephen Turner, Marco J. Herold, Tony Tiganis, Sammy Bedoui, Thomas Gebhardt

Summary: The deficiency of Ptpn2 affects the formation and function of TRM cells in the skin. The repression of KLRG1 is necessary for optimal TRM cell formation.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Biochemical Research Methods

Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies

Chen Li, Jerico Revote, Sri H. Ramarathinam, Shan Zou Chung, Nathan P. Croft, Katherine E. Scull, Ziyi Huang, Rochelle Ayala, Asolina Braun, Nicole A. Mifsud, Patricia T. Illing, Pouya Faridi, Anthony W. Purcell

Summary: This study utilized tandem mass spectrometry and proteomic techniques to analyze a dataset of MS/MS spectra derived from synthetic peptides of SARS-CoV-2, creating an online knowledgebase called virusMS. The database provides detailed annotations of peptides, experimental information, and predicted peptide-HLA binding affinities, aiding in vaccination target identification and immune monitoring research. VirusMS offers a user-friendly interface for easy access to the database content.

PROTEOMICS (2021)

Article Immunology

Varicella Zoster Virus Impairs Expression of the Nonclassical Major Histocompatibility Complex Class I-Related Gene Protein (MR1)

Shivam K. Purohit, Carolyn Samer, Hamish E. G. McWilliam, Renee Traves, Megan Steain, Brian P. McSharry, Paul R. Kinchington, David C. Tscharke, Jose A. Villadangos, Jamie Rossjohn, Allison Abendroth, Barry Slobedman

Summary: This study demonstrates that varicella zoster virus suppresses the expression of antigen presentation molecule MR1, highlighting the intricate temporal relationship between infection and ligand availability. The study also suggests that VZV likely encodes multiple viral genes targeting MR1.

JOURNAL OF INFECTIOUS DISEASES (2023)

Editorial Material Immunology

Editorial: The Immunology of Adverse Drug Reactions

Patricia T. Illing, Nicole A. Mifsud, Michael R. Ardern-Jones, Jason Trubiano

FRONTIERS IN IMMUNOLOGY (2022)

Article Microbiology

HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people

Jennifer Habel, Andrea Nguyen, Louise Rowntree, Christopher Szeto, Nicole Mifsud, E. Bridie Clemens, Liyen Loh, Weisan Chen, Steve Rockman, Jane W. Nelson, Jane Davies, Adrian Miller, Steven Y. C. T. Tong, Jamie Rossjohn, Stephanie M. Gras, Anthony Purcell, Luca M. Hensen, Katherine Kedzierska, Patricia M. Illing

Summary: HLA-A*11:01 is highly prevalent in East Asian and Oceanian populations and is associated with high risk of severe influenza disease. Using immunopeptidomics, researchers identified novel CD8(+) T cell targets for influenza A and influenza B viruses in HLA-A*11:01-expressing individuals. These findings have implications for the design of broadly cross-reactive influenza vaccines.

PLOS PATHOGENS (2022)

Article Chemistry, Multidisciplinary

Shielding Surfaces from Viruses and Bacteria with a Multiscale Coating

Deepu Ashok, Mahdiar Taheri, Puneet Garg, Daryl Webb, Pawan Parajuli, Yi Wang, Bronte Funnell, Bradley Taylor, David C. Tscharke, Takuya Tsuzuki, Naresh K. Verma, Antonio Tricoli, David R. Nisbet

Summary: This article reports on a sprayable coating that has the ability to resist the uptake and transmission of bacteria and viruses, while also providing bactericidal functionality and reducing viral contamination.

ADVANCED SCIENCE (2022)

Review Virology

Understanding the Role of HLA Class I Molecules in the Immune Response to Influenza Infection and Rational Design of a Peptide-Based Vaccine

A. K. M. Muraduzzaman, Patricia T. Illing, Nicole A. Mifsud, Anthony W. Purcell

Summary: Influenza A virus is a respiratory pathogen that causes significant damage to life and the economy. Current vaccines do not provide sufficient cross-protection, while vaccines that induce CD8(+) T cells have shown promise in providing cross-protection against different strains of the virus.

VIRUSES-BASEL (2022)

Article Biochemistry & Molecular Biology

Antiviral Effect of Ginsenosides rk1 against Influenza a Virus Infection by Targeting the Hemagglutinin 1-Mediated Virus Attachment

Xia Yang, Hailiang Sun, Zhening Zhang, Weixin Ou, Fengxiang Xu, Ling Luo, Yahong Liu, Weisan Chen, Jianxin Chen

Summary: Influenza A virus (IAV) infections pose a serious threat to public health and there is an urgent need for novel anti-IAV medications. This study reveals that ginsenoside rk1 (G-rk1) and G-rg5, derived from panax ginseng, exhibit significant antiviral effects against different IAV subtypes both in vitro and in vivo. G-rk1 specifically blocks IAV binding to sialic acid and interacts with HA1, making it a potential approach for preventing and treating IAV infections.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Allergy

The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-naive healthy donors

Nicole A. A. Mifsud, Patricia T. T. Illing, Rebecca Ho, Johanna E. E. Tuomisto, Heidi Fettke, Kerry A. A. Mullan, James McCluskey, Jamie Rossjohn, Julian Vivian, Rangsima Reantragoon, Anthony W. W. Purcell

Summary: Allopurinol is a drug used in the treatment of gout but can cause severe and life-threatening hypersensitivity reactions. People carrying the HLA-B*58:01 allotype are at higher risk. The drug metabolite oxypurinol is responsible for T cell-mediated immunopathology, and the TCR repertoire usage of reactive T cells in ALP-induced hypersensitivity reactions has been limitedly studied. This research shows that oxypurinol drives CD8(+) T cell responses and that drug-exposed memory T cells exhibit a proinflammatory immunophenotype. The study also supports the concept of pharmacological interaction with immune receptors and highlights oligoclonal and private clonotypic profiles of OXP-induced TCRs.

ALLERGY (2023)

Article Pharmacology & Pharmacy

Artesunate inhibits PDE4 leading to intracellular cAMP accumulation, reduced ERK/MAPK signaling, and blockade of influenza A virus vRNP nuclear export

Xia Yang, Feixiang Long, Weixin Jia, Mingxin Zhang, Guanming Su, Ming Liao, Zhenling Zeng, Weisan Chen, Jianxin Chen

Summary: We demonstrated that artemisinin and its derivative artesunate (AS) have broad antiviral activity against H5N1, H1N1, H3N2, and oseltamivir-resistant influenza A virus in vitro. AS treatment significantly protected mice from lethal challenges with H1N1 and H5N1 IAV, and the combination of AS and peramivir showed improved survival outcomes compared to monotherapy. Mechanistically, AS inhibited PDE4, induced cAMP accumulation, reduced ERK phosphorylation, and blocked IAV vRNP export, thus suppressing IAV replication.

ANTIVIRAL RESEARCH (2023)

Article Immunology

Detection of Clade 2.3.4.4b Avian Influenza A(H5N8) Virus in Cambodia, 2021

Kimberly M. Edwards, Jurre Y. Siegers, Xiaoman Wei, Ammar Aziz, Yi-Mo Deng, Sokhoun Yann, Chan Bun, Seng Bunnary, Leonard Izzard, Makara Hak, Peter Thielen, Sothyra Tum, Frank Wong, Nicola S. Lewis, Joe James, Filip Claes, Ian G. Barr, Vijaykrishna Dhanasekaran, Erik A. Karlsson

Summary: Institute in Cambodia collaborated with FAO to monitor AI virus in bird markets and poultry storage in Cambodia. The surveillance showed high levels of AIV circulation, with approximately 30%-50% of ducks and 20%-40% of chickens testing positive for various subtypes. The predominant subtypes were H5N1 during 2005-2014 and H5N1 and H5N6 since 2014, with sporadic detection of other subtypes including novel H7Nx in late 2021. Some samples tested positive for HPAIV H5 HA but negative for neuraminidase PCR, and further analysis confirmed them as H5N8 subtype.

EMERGING INFECTIOUS DISEASES (2023)

暂无数据